» Articles » PMID: 12225900

Cross-reactive Anti-galactocerebroside Antibodies and Mycoplasma Pneumoniae Infections in Guillain-Barré Syndrome

Overview
Journal J Neuroimmunol
Specialty Neurology
Date 2002 Sep 13
PMID 12225900
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Anti-galactocerebroside (GalC) antibodies are reported to be present in GBS patients with preceding Mycoplasma pneumoniae (MP) infection. We investigated the presence of anti-GalC reactivity in serum of a large group of GBS patients using ELISA and compared this with healthy controls and individuals with an uncomplicated MP infection. Anti-GalC antibody reactivity was present in 12% of the GBS patients. Furthermore, anti-GalC antibodies were associated with MP infections, a relatively mild form of the disease and demyelinating features. Anti-GalC antibodies cross-reacted with MP antigen. In conclusion, anti-GalC antibodies in GBS patients may be induced by molecular mimicry with MP.

Citing Articles

Engineering Mycoplasma pneumoniae to bypass the association with Guillain-Barré syndrome.

Broto A, Pinero-Lambea C, Segura-Morales C, Tio-Gillen A, Unger W, Burgos R Microbes Infect. 2024; 26(5-6):105342.

PMID: 38679229 PMC: 11234194. DOI: 10.1016/j.micinf.2024.105342.


Acute brainstem encephalitis associated with in an adult: a case report.

Woo M, Shin J Encephalitis. 2023; 1(4):120-123.

PMID: 37470051 PMC: 10295894. DOI: 10.47936/encephalitis.2021.00101.


Galactocerebroside biosynthesis pathways of Mycoplasma species: an antigen triggering Guillain-Barré-Stohl syndrome.

Gaspari E, Koehorst J, Frey J, Martins Dos Santos V, Suarez-Diez M Microb Biotechnol. 2021; 14(3):1201-1211.

PMID: 33773097 PMC: 8085918. DOI: 10.1111/1751-7915.13794.


Abnormal antibodies to self-carbohydrates in SARS-CoV-2 infected patients.

Butler D, Gildersleeve J bioRxiv. 2020; .

PMID: 33083799 PMC: 7574254. DOI: 10.1101/2020.10.15.341479.


Neurological Disorders Identified during Treatment of a SARS-CoV-2 Infection.

Wada S, Nagasaki Y, Arimizu Y, Shimo M, Matsukuma Y, Okamoto M Intern Med. 2020; 59(17):2187-2189.

PMID: 32713924 PMC: 7516316. DOI: 10.2169/internalmedicine.5447-20.